Health Care & Life Sciences » Biotechnology | Human Stem Cells Institute PJS

Human Stem Cells Institute PJS | Balance Sheet

Fiscal year is January-December. All values RUB Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
97
170
196
367
116
205
Total Accounts Receivable
77
68
60
90
114
50
Inventories
31
73
88
96
149
204
Other Current Assets
12
16
18
9
14
15
Total Current Assets
216
327
361
562
393
474
Net Property, Plant & Equipment
117
110
97
153
283
277
Total Investments and Advances
349
314
314
245
245
-
Long-Term Note Receivable
7
-
-
2
2
-
Intangible Assets
37
51
48
59
108
316
Total Assets
729
806
833
1,039
1,053
1,125
ST Debt & Current Portion LT Debt
92
99
90
39
51
Accounts Payable
6
4
12
88
73
Income Tax Payable
7
2
2
4
6
Other Current Liabilities
222
260
314
347
428
Total Current Liabilities
326
365
419
477
558
Long-Term Debt
37
-
25
307
363
Deferred Taxes
1
15
17
2
19
Total Liabilities
367
384
473
801
925
Common Equity (Total)
352
339
288
154
51
Total Shareholders' Equity
352
339
288
154
51
Total Equity
362
422
359
239
129
Liabilities & Shareholders' Equity
729
806
833
1,039
1,053
Accumulated Minority Interest
11
83
72
85
77

About Human Stem Cells Institute PJS

View Profile
Address
18/1, Olimpiyskiy Avenue
Moscow MC 129110
Russian Federation
Employees -
Website http://www.hsci.ru
Updated 07/08/2019
Human Stem Cells Institute OJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia.